METABOLISM OF GEMFIBROZIL

被引：39

作者：

OKERHOLM, RA ^{[1
]}

KEELEY, FJ ^{[1
]}

PETERSON, FE ^{[1
]}

GLAZKO, AJ ^{[1
]}

机构：

[1] PARKE DAVIS & CO,RES LABS,ANN ARBOR,MI 48106

来源：

PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON | 1976年 / 69卷

关键词：

D O I：

10.1177/00359157760690S204

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：11 / 14

页数：4

共 6 条

[1] [Anonymous], 1972, ICH guidelines, Q 3A(R)
[2] Impurities is new drug product. The quality guide lines for Active Pharmaceutical Ingredients related to impurities according to the international conference of harmonization 2002, Patent No. 3674836
[3] DAVISON C, 1975, DRUG METAB DISPOS, V3, P520
[4] HUCKER HB, 1971, J PHARMACOL EXP THER, V179, P359
[5] OKERHOLM RA, 1976, FED PROC, V35, P327
[6] BIOCHEMICAL ASPECTS OF TOXICOLOGY OF ATROMID
THORP, JM
[J]. JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1963, 3 (5-6): : 737 - 739